Drug policy news covering legalization efforts, DEA enforcement, opioid crisis, marijuana laws, and substance regulation developments.
U.S. Immigration and Customs Enforcement reduced fentanyl investigations by over 250,000 hours in the first year of the second Trump administration, coinciding with a 39% decline in seizures. An inspector general report found one field office dedicated 99% of work to immigration enforcement, prompting ICE to review staffing levels by June 2027.
India's Narcotics Control Bureau has initiated a year-long series of fortnightly special drives starting in September. The campaign targets absconding drug offenders, foreign nationals for deportation, and pharmaceutical diversion, aiming to dismantle trafficking syndicates across the country.
CDC figures show fentanyl-related fatalities fell from nearly 49,000 to 38,000 last year, with total overdose deaths declining 14%. The Trump administration attributes these improvements to border crackdowns and cartel targeting, while noting a significant decrease in seized fentanyl pills containing lethal doses.
The New York Post argues that the state's Cannabis Honestly campaign violates advertising laws by targeting minors and misleadingly frames marijuana as a safe medication. Citing medical studies, the author contends the taxpayer-funded initiative normalizes drug use among youth while ignoring evidence of cannabis's ineffectiveness for treating anxiety or depression.
The author argues that the 2018 hemp legalization loophole has created an unregulated national market for intoxicating products. Contrasting Texas's regulatory delay with Arkansas's successful enforcement, the piece contends that states retain authority to restrict these goods and urges immediate legislative action to prevent industry entrenchment.
A U.S. Attorney argues that the Trump administration's executive actions have reduced fentanyl purity, but contends Congress must enact lengthier mandatory minimum sentences for trafficking to dismantle drug organizations and deter dealers from entering the trade.
India's drug regulator has ordered states to stop all manufacturing and sales of unapproved enclomiphene medications. Authorities must identify and report on entities distributing the substance, which treats male infertility but lacks central licensing approval.
Malaysia's Court of Appeal substituted the mandatory death sentences of two men convicted of drug trafficking with 30 years' imprisonment and 12 strokes of the cane. The three-judge panel dismissed their appeals against conviction but allowed the appeals to set aside the death penalty, ruling that the trial judge's delay did not prejudice the appellants.
Costa Rican courts are reviewing 24 extradition requests involving citizens accused of international drug trafficking. The United States requested 20 suspects, while Panama and France each sought two. This follows a May 2025 constitutional reform ending the ban on extraditing citizens for drug offenses.